As already reported for mTOR and PI3K inhibitors, dietary intervention, glucose lowering medications, and treatment interruption with or without dose reduction can be helpful when hyperglycemia occurs, although multidisciplinary management is highly recommended (Esposito et al., 2019; Nunnery and Mayer, 2019). This evidence concerns the gene PIK3CA and Hyperglycemia.